Schizophrenia News and Research

Latest Schizophrenia News and Research

Viewpoints: 'Pent-up demand' for health care; too early for that White House victory lap; the fight over Medicare advantage

More than seven million people have signed up for insurance on the new federal and state health exchanges, President Obama said this week. Millions more could be added to that total once insurers tally up the people who bought policies directly from them and when those who tried to apply on balky websites are able to complete the process.

4 Apr 2014

Study reveals role of dopamine in hippocampus region of brain

Bruno Giros, PhD, a researcher at the Douglas Mental Health University Institute and a professor in the Department of Psychiatry at McGill University, has demonstrated, for the first time, the role that dopamine plays in a region of the brain called the hippocampus.

4 Apr 2014

Cognitive dysfunction reflected in schizophrenia healthcare costs

Cognitive dysfunction has direct and indirect effects on healthcare costs in patients with schizophrenia, research suggests.

3 Apr 2014

FDA clears Omeros' OMS721 IND for inhibition of complement‑mediated TMAs

Omeros Corporation today announced that its Investigational New Drug Application (IND) to evaluate OMS721 for the inhibition of complement‑mediated thrombotic microangiopathies (TMAs) has been cleared by the U.S. Food and Drug Administration.

3 Apr 2014

Study sheds light on brain mechanisms that make schizophrenia patients misinterpret what they see

People with schizophrenia often misinterpret what they see and experience in the world. New research provides insight into the brain mechanisms that might be responsible for this misinterpretation.

3 Apr 2014

Researchers generate high-resolution blueprint for how to build human brain

Researchers at the Allen Institute for Brain Science have generated a high-resolution blueprint for how to build a human brain, with a detailed map of where different genes are turned on and off during mid-pregnancy at unprecedented anatomical resolution.

3 Apr 2014

EnVivo Pharmaceuticals changes its name to FORUM Pharmaceuticals

EnVivo Pharmaceuticals, Inc. announced today that the company has changed its name to FORUM Pharmaceuticals Inc. The new name better reflects the company's strong position as a late-stage, purpose-built organization that is focused on conquering challenging brain diseases such as schizophrenia and Alzheimer's disease.

2 Apr 2014

Experimental anticancer compound appears to reverse behaviors associated with schizophrenia

Johns Hopkins researchers say that an experimental anticancer compound appears to have reversed behaviors associated with schizophrenia and restored some lost brain cell function in adolescent mice with a rodent version of the devastating mental illness.

1 Apr 2014

Geographical variation in antipsychotic efficacy not ruled out

An individual patient data meta-analysis fails to exclude the possibility that atypical antipsychotics work better in patients from some parts of the world than others.

31 Mar 2014

Cognitive deficits in bipolar patients ‘not homogenous’

Patients with bipolar disorder can be separated into three groups based on their cognitive performance, a study suggests.

31 Mar 2014

Forest Laboratories, Richter report positive results from cariprazine Phase IIb trial for bipolar depression

Forest Laboratories, Inc. and Gedeon Richter Plc. today announced positive topline results from a Phase IIb trial evaluating the efficacy and safety of the investigational antipsychotic cariprazine in patients with bipolar depression.

31 Mar 2014

Elsevier launches open access journal addressing role of cognitive functioning in schizophrenia

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the launch of Schizophrenia Research: Cognition, a new open access journal dedicated to publishing original research, concise research reports, brief reports, letters to the editor, and review papers addressing the role of cognitive functioning in schizophrenia.

28 Mar 2014

NARSAD grants to fund research into psychiatric illness by 40 mid-career scientists

The Brain & Behavior Research Foundation today announced its 2014 NARSAD Independent Investigator Grants, which will award $4 million in funding to 40 mid-career scientists from 33 institutions in nine countries. Selected by the Foundation's Scientific Council, comprised of 146 leading experts across disciplines in brain and behavior research including two Nobel Prize winners, the grants fund basic research, new technologies and next generation therapies for schizophrenia, major affective disorders, and other serious mental illnesses.

28 Mar 2014

Mirror neuron system faulty in schizophrenia patients

An imaging study suggests that a faulty mirror neuron system could underlie the social dysfunction seen in patients with schizophrenia.

27 Mar 2014

Schizophrenia Research: Cognition, an online open access journal from Elsevier

27 Mar 2014

Retrophin acquires Manchester Pharmaceuticals

Retrophin, Inc. today announced the completion of the previously announced acquisition of Manchester Pharmaceuticals LLC for a total of $62.5 million, including an upfront payment of $29.5 million, plus other payments based on product sales.

27 Mar 2014

Brain regions determine signals to stop drinking

The study found a 'stop mechanism' that determined brain signals telling the individual to stop drinking water when no longer thirsty, and the brain effects of drinking more water than required.

27 Mar 2014

Study seeks to adapt multi-family group treatment approach for people with spinal cord injury

Every year, more than 12,000 Americans-mostly young men-suffer spinal cord injuries in car crashes, falls, sports and acts of violence. Those dealing with this life-changing condition may soon have a better way to cope, thanks to a new collaborative research project by Washington State University Spokane and St. Luke's Rehabilitation Institute.

27 Mar 2014

Studying brain network changes in stroke patients possible with functional network connection models

Studies have shown that functional network connection models can be used to study brain network changes in patients with schizophrenia. A research team from Huazhong University of Science and Technology in China inferred that these models could also be used to explore functional network connectivity changes in stroke patients.

26 Mar 2014

First contact with psychiatric specialists hastens schizophrenia treatment

Patients with first-onset psychosis wait less time for treatment if they visit emergency clinics staffed by specialist psychiatric teams than their counterparts who access healthcare in community settings, report researchers.

21 Mar 2014

Schizophrenia News and Research

Latest Schizophrenia News and Research

Viewpoints: 'Pent-up demand' for health care; too early for that White House victory lap; the fight over Medicare advantage

Study reveals role of dopamine in hippocampus region of brain

Cognitive dysfunction reflected in schizophrenia healthcare costs

FDA clears Omeros' OMS721 IND for inhibition of complement‑mediated TMAs

Study sheds light on brain mechanisms that make schizophrenia patients misinterpret what they see

Researchers generate high-resolution blueprint for how to build human brain

EnVivo Pharmaceuticals changes its name to FORUM Pharmaceuticals

Experimental anticancer compound appears to reverse behaviors associated with schizophrenia

Geographical variation in antipsychotic efficacy not ruled out

Cognitive deficits in bipolar patients ‘not homogenous’

Forest Laboratories, Richter report positive results from cariprazine Phase IIb trial for bipolar depression

Elsevier launches open access journal addressing role of cognitive functioning in schizophrenia

NARSAD grants to fund research into psychiatric illness by 40 mid-career scientists

Mirror neuron system faulty in schizophrenia patients

Schizophrenia Research: Cognition, an online open access journal from Elsevier

Retrophin acquires Manchester Pharmaceuticals

Brain regions determine signals to stop drinking

Study seeks to adapt multi-family group treatment approach for people with spinal cord injury

Studying brain network changes in stroke patients possible with functional network connection models

First contact with psychiatric specialists hastens schizophrenia treatment

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Schizophrenia News and Research

Latest Schizophrenia News and Research

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in